Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/12/2025

First Trimester ANC Investigations

Essential Laboratory Investigations

  • Blood grouping and Rh typing must be performed to identify women requiring Rh immunoglobulin prophylaxis, according to the Obesity Reviews guideline society 1

Infectious Disease Screening

  • Hepatitis B surface antigen (HBsAg) testing is recommended as part of standard antenatal care by the Journal of Hepatology guideline society 2
  • HIV testing should be offered to all pregnant women, as recommended by the Journal of Hepatology guideline society 2
  • Screening for syphilis and other sexually transmitted infections should be performed, according to the Journal of Hepatology guideline society 2
  • Consider cytomegalovirus screening in specific clinical contexts, as suggested by the American Journal of Obstetrics and Gynecology guideline society 3

Blood Pressure and Cardiovascular Assessment

  • Women with chronic hypertension require closer monitoring throughout pregnancy, according to the Journal of Hepatology guideline society 2

Aneuploidy Screening

  • Cell-free DNA screening can be offered as a more sensitive option where cost permits, as recommended by the American Journal of Obstetrics and Gynecology guideline society 3, 4
  • Women with isolated soft markers on ultrasound should receive counseling about trisomy 18 risk and options for noninvasive screening, according to the American Journal of Obstetrics and Gynecology guideline society 3

Ultrasound Evaluation

  • Dating ultrasound should be performed in the first trimester to establish accurate gestational age, as recommended by the American Journal of Obstetrics and Gynecology guideline society 5
  • Assessment of chorionicity and amnionicity is mandatory for multiple pregnancies, according to the American Journal of Obstetrics and Gynecology guideline society 5

Pre-eclampsia Risk Stratification

  • Advanced maternal age (>35 years) is a maternal risk factor for pre-eclampsia, as identified by the Obesity Reviews guideline society 1
  • Obesity (BMI >30 kg/m²) is a maternal risk factor for pre-eclampsia, according to the Obesity Reviews guideline society 1
  • Diabetes mellitus is a maternal risk factor for pre-eclampsia, as identified by the Obesity Reviews guideline society 1

Prophylactic Interventions Based on First-Trimester Assessment

  • Folic acid 0.4 mg daily should be started preconceptionally and continued through the first trimester, as recommended by the Obesity Reviews guideline society 1, 6

Follow-up Monitoring Schedule

  • Repeat hemoglobin assessment every trimester, with more frequent monitoring in women with documented anemia or iron deficiency, as recommended by the Obesity Reviews guideline society 1, 6
  • Women on iron supplementation should have serum ferritin and iron studies rechecked every 3 months, according to the Obesity Reviews guideline society 1, 6

Early Screening for Fetal Chromosomal Anomalies at 12 Weeks

Why First-Trimester Screening at 12 Weeks

  • The American College of Medical Genetics recommends first-trimester combined screening, which includes nuchal translucency measurement and biochemical markers, at 11-14 weeks gestation, achieving detection rates of approximately 85-92% for Down syndrome with false-positive rates of 1-5% 7, 8
  • The American College of Medical Genetics suggests that the 12-week visit represents the ideal timing for comprehensive aneuploidy screening, which directly impacts pregnancy outcomes through early detection of lethal chromosomal abnormalities and major structural defects 7, 8

Optimal Detection Performance

  • First-trimester combined screening at 11-14 weeks achieves detection rates of approximately 85-92% for Down syndrome with false-positive rates of 1-5%, according to the American College of Medical Genetics 7, 8
  • The nuchal translucency measurement must be performed between 11 weeks 4 days and 13 weeks 6 days gestation, making the 12-week visit critical timing, as recommended by the American College of Obstetricians and Gynecologists 7, 9

Vaccination and Screening

  • The American College of Obstetricians and Gynecologists recommends Tdap vaccination in the third trimester, ideally between 27-36 weeks gestation, not at 12 weeks, to ensure optimal transplacental antibody transfer to provide passive immunity to the newborn against pertussis 10
  • The American Diabetes Association recommends gestational diabetes screening at 24-28 weeks gestation in the general population, not at 12 weeks, except for high-risk women who should undergo early diabetes screening to detect undiagnosed pre-existing type 2 diabetes 11

Risk Stratification and Prevention

  • The American Heart Association recommends blood pressure measurement at every prenatal visit, including the 12-week visit, to identify high-risk factors for preeclampsia, such as chronic hypertension, diabetes, obesity, advanced maternal age, previous preeclampsia, renal disease, and autoimmune disease 12
  • The American College of Obstetricians and Gynecologists recommends initiating low-dose aspirin (75-81 mg daily) starting at 12 weeks to reduce preeclampsia risk in high-risk women 12

Nutrition and Supplementation

  • The American College of Obstetricians and Gynecologists recommends confirming folic acid supplementation (0.4 mg daily for standard risk, 5 mg daily for women with BMI ≥30 or diabetes) through the end of the first trimester 10
  • The American College of Obstetricians and Gynecologists suggests considering aspirin 75-180 mg daily from 12 weeks for preeclampsia prevention in obese women (BMI ≥35) 9

REFERENCES